tirzepatide and zepbound the same Zepbound® (Tirzepatide) Eli Lilly Lowers Cost of

50% of patients with newly diagnosed cancer have hyperglycaemia, reflecting early beta-cell loss, fibrosis, impaired incretin secretion, and delayed alpha-cell atrophy [211]

Reduced Marketing Expenses Pharmaceutical companies spend billions on marketing

Psychiatric adverse events linked to glucagon-like peptide 1 analogues: a disproportionality analysis in American, Canadian and Australian adverse event databases[J]

Even under the new self-pay pricing, Zepbound from Eli Lilly now ranges in cost from $299 to $449 per month, depending on dosage

Verify current status with FDA orange-book listings and country-specific regulators before relying on this answer